Airway epithelial cells are pivotal in initiating and sustaining inflammation during allergic asthma, particularly in response to respiratory viral infections. The presence of a Th2 cytokine milieu—characterized by elevated IL-4 and IL-13—is a hallmark of allergic airway disease and is thought to influence epithelial cell function. This study investigated how pre-exposure to these cytokines alters the innate immune response of human bronchial epithelial cells (AEC) when challenged with double-stranded RNA (dsRNA), a surrogate for viral infection.

Primary human AEC were cultured in the presence or absence of IL-4 and IL-13 for 48 hours before stimulation with poly I:C, a dsRNA analog that activates TLR3 and RIG-I-like receptors. Gene expression analysis via quantitative real-time PCR revealed that Th2-pre-treated cells exhibited significantly increased mRNA levels of several pro-inflammatory chemokines, including CXCL8 (IL-8), CXCL9, CXCL10, CXCL11, and CCL5, following dsRNA challenge. These chemokines are known to recruit neutrophils, T cells, and eosinophils—key cellular mediators in asthmatic inflammation.

Concurrent protein assays confirmed robust secretion of CXCL8 and CCL5 into culture supernatants, with trends toward elevated CXCL10 and IL-6 levels. Notably, while IL-6 gene expression remained unchanged, protein levels showed a rise, suggesting possible release of pre-formed cytokine stores rather than de novo synthesis. This dissociation between mRNA and protein levels may reflect post-transcriptional regulation or delayed translation under inflammatory conditions.

In contrast, expression of antiviral genes was not suppressed. Instead, there was a significant upregulation of type III interferons (IFN-λ1/λ2/λ3), along with increased expression of RNA helicases DDX58 (RIG-I), DDX60, and IFIH1 (MDA-5), as well as transcription factors STAT1 and STAT2. These findings indicate that the intrinsic antiviral defense machinery remains intact—or even enhanced—in Th2-exposed epithelial cells. No changes were observed in IRF3 expression, a critical transcription factor for interferon production, suggesting that upstream signaling pathways remain functional.

The downregulation of IL-33 mRNA in Th2-pre-treated cells was unexpected, as IL-33 is a potent alarmin involved in amplifying Th2 responses. However, this may reflect feedback regulation within the epithelial microenvironment. In contrast, TSLP expression trended upward, consistent with its role in promoting dendritic cell activation and Th2 polarization.

These results demonstrate that a Th2 cytokine environment enhances the production of pro-inflammatory chemokines in airway epithelial cells upon viral mimicry, without compromising antiviral gene expression.Anti-TREM2 Antibody Purity & Documentation This pattern suggests that the exaggerated inflammatory response seen in allergic asthma during viral infections stems from amplified chemokine-driven recruitment of immune cells, rather than impaired host defense mechanisms.Monoethyl Purity & Documentation

Importantly, this study challenges the prevailing hypothesis that Th2 cytokines globally suppress antiviral immunity in AEC.PMID:35054962 Instead, it supports a model where inflammation is selectively amplified while core antiviral defenses are preserved or even augmented. This distinction has significant implications for therapeutic development: targeting chemokine pathways may reduce inflammation without increasing susceptibility to viral infections. Future studies should explore whether such strategies can mitigate exacerbations in allergic asthma without undermining essential immune protection.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

The identification of reliable biomarkers for predicting response to platinum-based chemotherapy is essential for personalizing cancer treatment and improving patient outcomes. Among the emerging candidates, copper transporter receptor 1 (CTR1) stands out due to its central role in mediating intracellular platinum accumulation. A growing body of clinical evidence supports CTR1 as a robust predictive biomarker for platinum sensitivity across multiple malignancies.

In ovarian cancer, tumor CTR1 mRNA levels have been consistently linked to treatment response. Patients with high CTR1 expression following optimal cytoreductive surgery exhibit significantly longer progression-free and overall survival after platinum therapy compared to those with low expression. These findings were validated using data from The Cancer Genome Atlas (TCGA), confirming that CTR1 expression correlates with improved clinical outcomes in advanced ovarian tumors treated with platinum agents. Similarly, in endometrial cancer, higher CTR1 protein levels detected by immunohistochemistry were associated with better disease-free and overall survival in patients receiving carboplatin-based regimens.

In non-small cell lung cancer (NSCLC), CTR1 expression has proven predictive in both neoadjuvant and adjuvant settings. In a cohort of 30 NSCLC patients who received neoadjuvant platinum chemotherapy, undetectable CTR1 levels in tumor specimens correlated with reduced intratumoral platinum concentration and lack of tumor response. Another study involving 54 stage III NSCLC patients demonstrated that higher CTR1 expression was independently associated with longer progression-free survival (P = 0.01) and overall survival (P = 0.047). These results suggest that CTR1 status may help identify patients likely to benefit from platinum-based regimens.

Bladder cancer provides additional compelling evidence. In muscle-invasive bladder cancer patients undergoing neoadjuvant cisplatin-based chemotherapy, tumor CTR1 expression in cystectomy specimens significantly predicted pathologic downstaging—a key indicator of treatment efficacy. Patients with high CTR1 levels showed greater tumor shrinkage and improved recurrence-free survival, reinforcing CTR1’s potential as a pre-treatment biomarker.

Beyond expression levels, genetic polymorphisms in the CTR1 gene also influence clinical outcomes. Studies in Chinese NSCLC populations revealed that specific single nucleotide polymorphisms (SNPs)—such as rs7851395 and rs12686377—were associated with platinum resistance and poor prognosis. The GT haplotype conferred increased susceptibility to resistance, while the AG haplotype was linked to longer survival. Another SNP, rs10981694, correlated with platinum-induced toxicity but did not significantly affect survival, suggesting context-dependent roles of these variants.

Given its pivotal function, CTR1 has emerged as a promising therapeutic target to overcome platinum resistance. Strategies aimed at enhancing CTR1 expression or preventing its degradation are currently under investigation. Copper chelators such as tetrathiomolybdate (TTM) and D-penicillamine lower intracellular copper, leading to compensatory upregulation of CTR1. Preclinical studies show that combining TTM with cisplatin enhances tumor platinum uptake and improves antitumor effects in resistant ovarian and cervical cancer models.7-Hydroxycoumarin glucuronide Autophagy Notably, in oxaliplatin-resistant cervical carcinoma cells, D-penicillamine restored sensitivity by increasing CTR1 expression via Sp1 activation.EphA2 ProteinMedChemExpress

Another approach involves blocking CTR1 degradation. The proteasome inhibitor bortezomib has been shown to stabilize CTR1 in mouse fibroblasts and human ovarian cancer cells, resulting in increased platinum accumulation and synergistic cytotoxicity. This mechanism is particularly relevant since cisplatin itself triggers rapid CTR1 degradation.PMID:34774755 Clinical trials are now underway to evaluate intraperitoneal bortezomib combined with carboplatin in recurrent ovarian cancer (NCT01074411).

Nutritional modulation also holds promise. Zinc supplementation has been associated with increased CTR1 expression and enhanced platinum uptake in vitro. A double-blind, placebo-controlled trial in nasopharyngeal carcinoma patients found that daily zinc (75 mg) significantly improved overall survival, local control, and disease-free survival compared to placebo. Green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) similarly upregulates CTR1 mRNA and protein levels, enhancing platinum accumulation and DNA adduct formation in ovarian cancer cells.

In summary, CTR1 is not only a strong predictor of platinum response but also a viable target for therapeutic intervention. Its expression level, genetic variation, and dynamic regulation offer opportunities for precision oncology approaches. Future efforts should focus on integrating CTR1 assessment into clinical decision-making and advancing combination strategies that exploit copper homeostasis to reverse platinum resistance and improve survival in solid tumors.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

The volatile organic compounds (VOCs) produced by *Muscodor albus* MOW12 were comprehensively analyzed using gas chromatography-mass spectrometry (GC-MS) to elucidate their chemical composition and biological significance. The VOC profile was generated from a 10-day-old culture grown on potato dextrose agar (PDA) at 23 °C, with headspace sampling performed under controlled conditions. The analysis revealed a total of ten major compounds, predominantly esters, alcohols, and carboxylic acids, each contributing uniquely to the overall antimicrobial efficacy of the fungal volatiles.

Ethanol emerged as the most abundant compound, accounting for 71.2% of the total volatile content. This high concentration is unprecedented among known *M. albus* isolates, where ethanol typically constitutes a minor fraction. Other significant components included acetic acid ethyl ester (4.7%), hexanal (5.1%), and acetic acid, 2-methylpropyl ester (8.0%). Additional compounds identified were 2-methyl-1-propanol (2.4%), 2-methyl-propanoic acid methyl ester (2.4%), pentanal (1.0%), and 2-methyl-1-butanol (8.0%). Notably, styrene and 3-methyl-1-butanol acetate were detected in trace amounts (0.5–0.8%). These findings confirm a distinct metabolic signature for MOW12, differentiating it from previously characterized *Muscodor* strains.

The presence of such a diverse array of small molecular weight VOCs suggests a complex biosynthetic pathway involving fatty acid metabolism and alcohol oxidation. Ethanol, in particular, may act synergistically with other compounds to disrupt microbial cell membranes and inhibit respiratory enzymes. Esters like acetic acid ethyl ester and its derivatives are known to interfere with membrane integrity, while aldehydes such as hexanal exhibit strong antimicrobial activity against fungi and bacteria. The combined action of these compounds likely contributes to the broad-spectrum inhibition observed in bioassays.

Biological testing demonstrated that the VOC mixture effectively inhibited or killed a wide range of plant pathogens, including *Sclerotinia* sp., *Pythium* sp., *Botrytis* sp., *Aspergillus* sp., and *Phytophthora palmivora*, all showing complete growth suppression. However, *Fusarium* sp. exhibited partial resistance (40% inhibition), and *Trichoderma* sp.2,5-Dimethoxyterephthalicacid custom synthesis showed only 10% inhibition—significantly lower than the 20–70% inhibition seen with other *M.Triphenylamine Biological Activity albus* strains.PMID:35134469 This differential sensitivity indicates potential strain-specific variations in target organism susceptibility.

Mechanistically, the VOCs act primarily through vapor-phase diffusion without requiring direct contact. The split-plate assay confirmed that inhibition occurred exclusively via volatile compounds, as no soluble inhibitors could diffuse across the agar channel. This mode of action makes *M. albus* MOW12 ideal for applications in enclosed environments such as seed storage, post-harvest treatment, and soil fumigation.

In conclusion, the unique VOC profile of *M. albus* MOW12—dominated by ethanol and a mix of esters and aldehydes—represents a novel biochemical signature with high biotechnological potential. Its ability to suppress pathogenic fungi without relying on spore production or fruiting bodies enhances its suitability for industrial and agricultural use. Further research into the biosynthesis of these compounds and their application in biocontrol systems is warranted, particularly in sustainable agriculture and crop protection.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

Objective: To examine the association between fish consumption, erythrocyte omega-3 fatty acid levels, and preterm birth in a cohort of women with prior spontaneous preterm delivery. Methods: This was a secondary analysis of data from a multicenter randomized controlled trial evaluating omega-3 fatty acid supplementation for the prevention of recurrent preterm birth. Dietary fish intake was assessed using a validated food frequency questionnaire at baseline enrollment among 852 women. Erythrocyte fatty acid composition was measured at midpregnancy (20–24 weeks’ gestation) in a subset of participants. The primary outcome was preterm birth (<37 weeks’ gestation). Secondary outcomes included early preterm birth (<34 weeks) and late preterm birth (34–36 6/7 weeks). Multivariable logistic regression models were used to assess associations between fish consumption, erythrocyte omega-3 levels, and preterm birth, adjusting for treatment assignment, number of prior preterm deliveries, smoking status, race/ethnicity, body mass index, clinical center, and earliest gestational age of prior preterm birth. Results: Among 852 women, 41.7% delivered before 37 weeks. Women consuming at least one fish meal per week had a lower rate of preterm birth (33.7%) compared to those consuming less than one meal per week (44.4%), with an adjusted odds ratio of 0.68 (95% CI, 0.48–0.96; p = .03). A U-shaped relationship was observed: the lowest risk of preterm birth occurred among women consuming 1–3 fish meals per week, while risk increased again among those consuming four or more meals per week. Erythrocyte docosahexaenoic acid (DHA) levels were significantly higher in women who consumed more fish, but no significant association was found between DHA levels and preterm birth after adjustment for confounders. Omega-3 supplementation did not modify the association between fish intake and preterm birth. Conclusion: Higher fish consumption, particularly 1–3 meals per week, is associated with reduced risk of recurrent preterm birth in women with a history of spontaneous preterm delivery. However, very high fish intake may be associated with increased risk, suggesting a potential threshold effect. Clinical Trial Registration: ClinicalTrials.gov, www.clinicaltrials.gov, NCT00135902. Introduction Preterm birth remains a leading cause of neonatal morbidity and mortality worldwide. Despite advances in obstetric care, recurrence rates remain high among women with prior spontaneous preterm birth. Inflammation, immune dysregulation, and nutritional factors have been implicated in the pathophysiology of preterm labor. Omega-3 polyunsaturated fatty acids (PUFAs), particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are known to modulate inflammatory pathways and may play a role in pregnancy maintenance. Fish is a major dietary source of these beneficial fatty acids. Previous studies have shown mixed results regarding the impact of fish consumption on preterm birth, with some reporting protective effects and others finding no association. Furthermore, few studies have examined the relationship between actual erythrocyte fatty acid levels and preterm birth in high-risk populations. We conducted this analysis to evaluate whether fish consumption and erythrocyte omega-3 fatty acid concentrations are associated with preterm birth in a well-characterized cohort of women with prior spontaneous preterm delivery. We hypothesized that higher fish intake and elevated erythrocyte DHA levels would be associated with reduced risk of preterm birth, particularly among those with recurrent preterm delivery. Methods This study utilized data from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network randomized trial of omega-3 fatty acid supplementation to prevent recurrent preterm birth (NCT00135902). The trial enrolled 852 women with a documented history of at least one prior singleton preterm birth between 20 0/7 and 36 6/7 weeks' gestation due to spontaneous preterm labor or preterm premature rupture of membranes. Participants were randomized to receive either 2,000 mg/day of long-chain omega-3 PUFAs or matching placebo capsules, in addition to weekly injections of 17 alpha-hydroxyprogesterone caproate (17OHPC). All women provided written informed consent and were enrolled between 16 and 21 6/7 weeks’ gestation. Fish diet history was assessed at baseline using a semiquantitative food frequency questionnaire including items for dark-meat fish, canned tuna, other fish, and shellfish. Total fish intake was categorized as <1 meal per week versus ≥1 meal per week. For a subset of 365 women, erythrocyte fatty acid profiles were analyzed at midpregnancy (20–24 weeks) via gas chromatography.3-Penten-2-one Cancer Fatty acids were expressed as percent of total fatty acids. The primary outcome was preterm birth (<37 weeks), and secondary outcomes included early preterm birth (<34 weeks) and late preterm birth (34–36 6/7 weeks). Statistical analyses included descriptive comparisons, univariate and multivariable logistic regression models.2,5-Diiodoterephthalic acid supplier Adjusted models accounted for treatment assignment, number of prior preterm deliveries, smoking status, race/ethnicity, body mass index, clinical center, and earliest gestational age of prior preterm birth.PMID:35021925 A p-value < .05 was considered statistically significant. All analyses were performed using SAS version 9.4. Results Among the 852 women enrolled, the overall rate of preterm birth was 41.7%. Women who consumed at least one fish meal per week had a significantly lower rate of preterm birth (33.7%) compared to those consuming less than one meal per week (44.4%), with an unadjusted odds ratio of 0.67 (95% CI, 0.55–0.82; p < .001). After adjusting for multiple covariates, the adjusted odds ratio remained significant at 0.68 (95% CI, 0.48–0.96; p = .03). When examining fish consumption by frequency, a U-shaped relationship emerged: the lowest risk was observed in women consuming 1–3 meals per week (adjusted OR 0.59, 95% CI 0.42–0.83), while risk increased among those consuming four or more meals per week (adjusted OR 1.04, 95% CI 0.68–1.58), although the latter was not statistically significant. Erythrocyte DHA levels were significantly higher in women consuming more fish (p < .001). However, when DHA levels were analyzed as continuous variables in multivariable models, no significant association with preterm birth was found (adjusted OR per 1% increase in DHA: 0.98, 95% CI 0.94–1.02; p = .27). Similarly, EPA levels showed no independent association with preterm birth. Omega-3 supplementation did not alter the protective effect of moderate fish consumption. No significant interaction was observed between fish intake and treatment group (p = .61). Discussion Our findings indicate that fish consumption is independently associated with a reduced risk of recurrent preterm birth among women with prior spontaneous preterm delivery. The protective effect was most pronounced among those consuming 1–3 fish meals per week, suggesting a possible optimal range. The lack of benefit and potential increase in risk among women with very high fish intake raises concerns about excessive exposure, possibly due to contaminants such as mercury or polychlorinated biphenyls (PCBs), which may offset any anti-inflammatory benefits. While erythrocyte DHA levels correlated with fish intake, they did not predict preterm birth in this cohort, indicating that dietary patterns may be more informative than biomarker levels alone. This finding aligns with broader evidence that the context of nutrient intake—such as food matrix, co-consumed nutrients, and timing—is critical. Our results also suggest that omega-3 supplementation does not substitute for dietary fish intake, nor does it enhance its protective effect. This may reflect differences in bioavailability, dose, or the presence of synergistic compounds found in whole fish. Strengths of this study include a large, high-risk population, standardized data collection across centers, and objective measurement of erythrocyte fatty acids. Limitations include the observational nature of the secondary analysis, potential residual confounding, and limited generalizability beyond women with prior preterm birth. Additionally, fish intake was self-reported and subject to recall bias. Future research should explore the mechanisms underlying the U-shaped relationship and investigate whether specific types of fish or preparation methods influence outcomes. Studies incorporating biomarkers alongside detailed dietary assessments and long-term infant outcomes would further clarify the role of fish in pregnancy health.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

The accurate quantification of gene expression in ovarian tumours hinges on the use of stably expressed reference genes (RGs) for normalization in RT-qPCR assays. This study systematically evaluated 13 candidate RGs—ABL1, ACTB, CDKN1A, GADPH, GUSB, HPRT1, HSP90AB, IPO8, PPIA, RPL30, RPL4, RPLPO, and TBP—in a cohort of 42 primary ovarian tumours encompassing benign, borderline, and malignant subtypes with diverse histological origins. Total RNA was extracted from frozen tissue samples and reverse-transcribed into cDNA. Quantitative RT-qPCR was performed using pre-designed TaqMan assays targeting exon junctions to avoid genomic DNA amplification. Amplification efficiencies ranged between 85% and 99%, with standard curves exhibiting high linearity (r² > 0.998). Statistical analysis was conducted using GeNorm, NormFinder, BestKeeper, and the Equivalence test to assess expression stability across tumour groups. GeNorm identified IPO8 and RPL4 as the most stable genes, followed by TBP and RPLPO. NormFinder ranked TBP, RPLPO, IPO8, ACTB, and RPL4 as the top five stable candidates, with consistent rankings across subgroup analyses including serous, mucinous, and endometrioid tumours. BestKeeper confirmed low standard deviation in Ct values for IPO8 (SD = 0.65), indicating minimal variation. The Equivalence test revealed that only IPO8 met the stringent 2-fold expression change criterion across all subgroups, while others showed significant variability. Notably, GADPH and HPRT1 failed stability criteria in multiple comparisons. Functional validation using target genes GPER and uPAR demonstrated that normalization to IPO8 or RPL4 yielded biologically consistent results, whereas GADPH- or HPRT1-based normalization led to misleading conclusions.Ifosfamide In Vitro These findings confirm IPO8 and RPL4 as superior reference genes for ovarian tumour studies, particularly in heterogeneous populations.Decanamide manufacturer In contrast, traditional RGs such as GADPH and HPRT1 are unsuitable due to variable expression influenced by tumour grade and histology.PMID:34907534 This work emphasizes the critical importance of context-specific RG validation to ensure reliable and reproducible gene expression data in ovarian cancer research.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

Triple negative breast cancer (TNBC) remains a significant clinical challenge due to its aggressive behavior, lack of hormone receptors, and absence of HER-2 amplification, which limits the availability of targeted treatment options. However, emerging evidence has highlighted the frequent amplification and overexpression of epidermal growth factor receptor (EGFR) in TNBC, suggesting that EGFR may serve as a viable therapeutic target. This study aimed to evaluate the prevalence and molecular characteristics of EGFR alterations in a cohort of 138 TNBC cases using standardized pathological and molecular techniques.

Using silver in situ hybridization (SISH), immunohistochemistry (IHC), and quantitative PCR (qPCR), we assessed EGFR status across both large tissue sections and tissue microarray (TMA) cores. The results revealed that EGFR amplification was present in 92% of TNBC cases evaluated by TMA and 87% in large sections, indicating a high frequency of genomic amplification.8-Methoxyquinoline Protocol SISH demonstrated strong concordance with qPCR, showing 94% specificity and 75.6% sensitivity, validating the reliability of SISH as a cost-effective method for routine clinical use. IHC correlated well with SISH, achieving 97% sensitivity and 78% specificity, reinforcing its value as an initial screening tool in pathology laboratories.

Importantly, no activating mutations in EGFR exons 18–21 were detected, nor were any Kras mutations or EML4-ALK translocations identified. This aligns with current literature indicating that EGFR mutations are uncommon in TNBC, particularly in non-Asian populations. Instead, we observed PI3K mutations in 35% of cases and BRAF mutations in 13.CDKN1A Antibody Purity & Documentation 8%, suggesting that aberrations in downstream signaling pathways may play a critical role in tumor biology and resistance to EGFR inhibition.

A striking finding was the identification of extrachromosomal double minute (DM) structures in 18% of SISH-positive cases, characterized by linear or curved arrangements of silver dots in the cytoplasm near the nuclear membrane—reminiscent of patterns seen in glioblastomas.PMID:35082689 These DMs represent an alternative mechanism of EGFR gene amplification and may contribute to sustained oncogene expression and therapeutic resistance.

Our data support the integration of SISH and IHC into standard clinical workflows for TNBC evaluation. These methods enable accurate detection of EGFR amplification and protein overexpression, which are key predictors of potential response to anti-EGFR therapies. Given the high prevalence of EGFR dysregulation in TNBC, patients with amplified tumors may be candidates for treatment with monoclonal antibodies such as cetuximab. However, due to the frequent co-occurrence of PI3K and BRAF mutations, combination therapy targeting both EGFR and these downstream effectors may be necessary to overcome intrinsic resistance mechanisms.

In conclusion, EGFR amplification without mutation is a common feature in TNBC, making it a promising target for precision medicine. Future clinical trials should incorporate robust molecular profiling—including ISH and IHC—to select patients most likely to benefit from EGFR-directed therapies, thereby improving outcomes in this aggressive breast cancer subtype.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

Long chain omega-3 polyunsaturated fatty acids (LC n-3 PUFAs) are known to confer cardiovascular benefits through the improvement of endothelial function. Endothelial cells store von Willebrand factor (vWF) within cytoplasmic Weibel-Palade bodies (WPBs), which play a key role in hemostasis and inflammation. This study investigated whether LC n-3 PUFAs regulate WPB degranulation using cultured human umbilical vein endothelial cells (HUVECs). HUVECs were incubated with or without 75 or 120 µM docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA) for five days at 37°C. Subsequently, degranulation was induced using phorbol 12-myristate 13-acetate (PMA), and assessed via immunocytochemical staining for vWF. Actin cytoskeletal reorganization was evaluated using phalloidin-TRITC staining.3-Methyl-3-buten-1-ol Biological Activity The results showed that PMA stimulation significantly induced WPB degranulation, an effect that was markedly reduced by prior exposure to LC n-3 PUFAs.ROR gamma T Antibody Autophagy In these treated cells, WPBs exhibited a rounded morphology instead of their typical rod shape and were localized near the perinuclear region, indicating interference with actin-dependent cytoskeletal remodeling necessary for complete exocytosis.PMID:35174895 Consistent with this, actin rearrangement was altered: cells with perinuclear WPBs displayed a thickened cortical actin rim but lacked prominent cytoplasmic stress fibers. These findings suggest that LC n-3 PUFAs inhibit full WPB degranulation by disrupting actin cytoskeletal dynamics, potentially contributing to their anti-thrombotic effects observed in vivo. This provides new insight into how omega-3 fatty acids may protect against vascular inflammation and thrombosis by modulating endothelial storage granule release.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

Transverse aortic constriction is a well-established experimental technique used in rodents to induce pressure overload, leading to left ventricular hypertrophy (LVH) and eventually heart failure. Over time, various methods have been developed to perform this procedure, evolving from open-chest surgery to minimally invasive transcervical approaches. Our laboratory previously introduced a murine model involving transverse aortic arch constriction using a slip-knot suture followed by subsequent band removal to study LVH regression and reverse remodelling. However, several limitations hindered its widespread adoption. The suture technique proved technically challenging due to the fragility of the mouse aorta, inconsistent tension during knot tying, and risk of suture loosening over time. Moreover, inflammatory response around the suture made later removal difficult and often resulted in adhesions or unintended trauma.

To overcome these challenges, we developed a modified approach utilizing a titanium clip for both constriction and release. This method offers improved reproducibility, reduced surgical complexity, and greater reliability in maintaining consistent pressure gradients. In this study, 95 male C57BL/6 mice aged 8–10 weeks were used, weighing between 20 and 30 grams. Animals were assigned to one of six groups: sham control, three-week aortic banding (AB), four-week AB, six-week AB, three-week AB with one-week debanding (DB), four-week AB with one-week DB, and six-week AB with either one- or two-week DB. All procedures were conducted under an institutional animal care protocol.

Mice were anesthetized via intraperitoneal injection of ketamine (100 mg/kg) and xylazine (10 mg/kg). A minimally invasive technique was employed to access the aortic arch without thoracotomy. A small incision was made at the suprasternal notch, and the sternum was partially exposed after retraction of the thyroid and pretracheal muscles. Tension sutures were placed on each side to facilitate visualization. A calibrated microclip applicator was adjusted using a 27-gauge needle to ensure uniform constriction force across all animals. Sterile titanium clips (Hemoclip Plus, Weck Closure Systems) were then placed between the origins of the left carotid and innominate arteries. Carotid Doppler velocity measurements confirmed a consistent three- to fourfold pressure gradient immediately post-placement.

After the designated period, clips were removed through the same incision site. A modified clip remover—derived from a micro needle holder with a diamond-shaped tooth—was used to grasp and open the clip perpendicularly to its insertion plane.Hexane-1,6-diamine In Vitro This allowed safe and efficient removal without damaging surrounding tissue.Nefazodone References Of the 95 mice, eight died during or shortly after AB surgery, and three succumbed during DB procedures.

Echocardiography was performed using a Vivid 5 system with a 15 MHz linear probe. Mice were anesthetized with 1%–1.5% isoflurane, and heart rate was maintained between 520 and 580 beats per minute. Parameters such as interventricular septal thickness (IVSd/s), left ventricular internal dimensions (LVIDd/s), posterior wall thickness (LVPWd/s), ejection fraction (EF), and fractional shortening (FS) were measured. Heart weight-to-body weight (HW/BW) and lung weight-to-body weight (LW/BW) ratios were calculated at necropsy.PMID:35087536

Results showed that three- and four-week AB induced significant concentric LVH with preserved systolic function. By six weeks, hearts exhibited progressive dilation, decreased EF, increased LVEDP, and elevated lung weights indicating pulmonary congestion. Importantly, clip removal after three or four weeks led to significant regression of hypertrophy and normalization of cardiac function (HW/BW from 7.33±0.77 to 5.75±0.31 and 7.42±0.49 to 6.05±0.77, respectively; p<0.05). In contrast, removal after six weeks failed to restore function—LV end-diastolic pressure remained elevated, and no improvement in contractility was observed. Direct catheterization confirmed impaired +dp/dt and -dp/dt in six-week banded animals, indicating irreversible dysfunction. In conclusion, the titanium clip-based model provides a highly reproducible, minimally invasive method for inducing and relieving pressure overload in mice. It enables precise control of constriction intensity, avoids suture-related complications, and allows reliable assessment of reverse remodelling. This model is particularly valuable for studying the molecular and cellular mechanisms underlying recovery from heart failure and may serve as a robust platform for evaluating novel therapeutic interventions aimed at reversing adverse cardiac remodelling.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

Melanoma remains one of the most lethal forms of skin cancer, particularly when it progresses to metastatic stages. Despite advances in targeted therapies and immunotherapies, the prognosis for patients with advanced melanoma remains grim, with median survival ranging from 6 to 10 months and a 5-year survival rate below 20%. Dacarbazine (DTIC), the standard chemotherapeutic agent for metastatic melanoma, demonstrates limited efficacy, benefiting only 5%–10% of patients. The development of resistance to both conventional chemotherapy and targeted agents such as BRAF inhibitors like vemurafenib and dabrafenib is a major barrier to effective treatment. While genetic mutations and epigenetic alterations in key signaling pathways—especially the PI3K/Akt pathway—are known contributors to drug resistance, the role of extracellular factors such as insulin has been underexplored.

This study investigates whether insulin, a hormone commonly elevated in conditions such as obesity and type II diabetes, contributes to therapeutic resistance in melanoma cells. We focused on its effects on DTIC and the mutant BRAF inhibitor PLX4720, particularly in BRAFV600E-mutant melanoma cells. Our findings demonstrate that insulin significantly reduces the cytotoxicity of both drugs in melanoma cell lines, including B16 (wild-type BRAF) and Mel-RMu (BRAFV600E).Gremlin-1 Proteinsupplier Pre-incubation with insulin at 250 nM increased cell viability by up to 40% in Mel-RMu cells and 25% in B16 cells following DTIC exposure. Similarly, insulin attenuated the killing effect of PLX4720 on BRAFV600E melanoma cells.

Mechanistically, insulin activates the PI3K/Akt pathway, as evidenced by increased phosphorylation of Akt at Ser473 in both cell lines. This activation was confirmed through Western blot analysis. To determine if this pathway mediates insulin-induced resistance, we employed two pharmacological inhibitors: LY294002, a selective PI3K inhibitor, and BEZ-235, a dual inhibitor of PI3K and mTOR.2-Fluoroterephthalic acid Technical Information Both compounds effectively reversed insulin’s protective effects.PMID:35062322 In the presence of either inhibitor, insulin no longer conferred resistance to DTIC or PLX4720. Moreover, BEZ-235 alone enhanced the cytotoxicity of PLX4720, indicating that suppression of PI3K/Akt signaling sensitizes melanoma cells to BRAF inhibition.

These results highlight a critical link between metabolic status and treatment response in melanoma. Elevated circulating insulin levels may impair the efficacy of chemotherapy and targeted therapy by activating pro-survival signals through PI3K/Akt. Therefore, patients with obesity or type II diabetes may experience suboptimal outcomes due to intrinsic insulin-driven resistance. Targeting the PI3K/Akt pathway with inhibitors such as BEZ-235 or LY294002 could potentially overcome this resistance and improve therapeutic outcomes. These findings support the clinical evaluation of combination therapies involving PI3K/Akt inhibitors and existing melanoma treatments, especially in high-insulin populations.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

Bendamustine, a bifunctional alkylating agent with a purine-like structure, has demonstrated significant clinical activity against indolent lymphoid malignancies either as a single agent or in combination with rituximab. However, for refractory or relapsed cases, including mantle cell lymphoma, diffuse large B-cell lymphoma, aggressive lymphomas, and multiple myeloma—tumors relatively resistant to bendamustine—combination therapy with additional anti-cancer agents is often necessary. This study aimed to identify optimal drugs for combination with bendamustine and elucidate the underlying mechanisms of synergism.Riociguat Guanylate Cyclase

Isobologram analysis revealed that bendamustine exhibited synergistic effects with alkylating agents (4-hydroperoxy-cyclophosphamide, chlorambucil, melphalan) and pyrimidine analogues (cytosine arabinoside, gemcitabine, decitabine) in HBL-2, B104, Namalwa, and U266 cell lines representing the aforementioned malignancies.3-(Dimethylamino)benzoic acid manufacturer Cell cycle analysis showed that bendamustine induced late S-phase arrest, which was further enhanced by 4-hydroperoxy-cyclophosphamide, while it potentiated early S-phase arrest caused by cytosine arabinoside, leading to a marked increase in sub-G1 fractions—a hallmark of apoptosis.

Notably, bendamustine elicited DNA damage response and apoptosis more rapidly and with shorter exposure times than other alkylating agents, due to its efficient intracellular incorporation via equilibrative nucleoside transporters (ENTs).PMID:35078375 Moreover, bendamustine upregulated ENT1 expression at both mRNA and protein levels, significantly enhancing the uptake of cytosine arabinoside and increasing intracellular Ara-CTP concentrations to levels comparable to those achieved with the purine analogue fludarabine.

These findings indicate that the purine analog-like properties of bendamustine are central to its unique pharmacological profile. By facilitating rapid cellular entry and amplifying the activity of pyrimidine analogues through transporter upregulation, bendamustine creates a favorable context for synergistic drug interactions. This mechanistic insight provides a strong theoretical foundation for developing more effective bendamustine-based combination regimens, particularly for treatment-resistant lymphoid malignancies.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com